FK 506SEWING, K.-F; CHRISTIANS, U.Lancet (British edition). 1991, Vol 337, Num 8739, issn 0140-6736, p. 499Article

Effect of FK-506, a novel immunosuppressive drug on murine systemic lupus erythematosusTAKABAYASHI, K; KOIKE, T; KURASAWA, K et al.Clinical immunology and immunopathology (Print). 1989, Vol 51, Num 1, pp 110-117, issn 0090-1229, 8 p.Article

FK506 : the promise and the paradoxWHITE, D. J. G.Clinical and experimental immunology (Print). 1991, Vol 83, Num 1, pp 1-3, issn 0009-9104, 3 p.Article

Proceedings/1st. International workshop on FK-506, a potential breakthrough in immunosuppression: 3rd. congress of the European Society ofr Organ Transplantation, Göteborg, 1987IWASAKI, Y.Transplantation proceedings. 1987, Vol 19, Num 5, issn 0041-1345, 104 p., suppl. 6Conference Proceedings

Immunosuppressive macrolidesSTÜTZ, A.Transplantation proceedings. 1992, Vol 24, Num 4, pp 22-25, issn 0041-1345, SUP2Conference Paper

Diabetogenicity of FK506 versus cyclosporine in liver transplant recipientsJINDAL, R. M; POPESCU, I; SCHWARTZ, M. E et al.Transplantation. 1994, Vol 58, Num 3, pp 370-372, issn 0041-1337Article

FK 506, un progrès dans l'immunosuppression des greffes d'organesCHEVREL, B.Médecine et chirurgie digestives (Paris). 1993, Vol 22, Num 3, pp 189-195, issn 0047-6412Article

Cyclosporin A, FK-506, and rapamycin : pharmacologic probes of lymphocyte signal transductionSIGAL, N. H; DUMONT, F. J.Annual review of immunology. 1992, Vol 10, pp 519-560, issn 0732-0582Article

The effect of FK506 treatment on pancreaticoduodenal allotransplantation in the primateERICZON, B.-G; WIJNEN, R. M. H; TIEBOSCH, A et al.Transplantation. 1992, Vol 53, Num 6, pp 1184-1189, issn 0041-1337Article

Comparison of the in vitro and biophysical effects of cyclosporine A, FK-506, and mycophenolic acid on human peripheral blood lymphocytesWEAVER, J. L; PINE, P. S; ASZALOS, A et al.Immunopharmacology and immunotoxicology. 1991, Vol 13, Num 4, pp 563-576, issn 0892-3973Article

Expérience clinique du FK 506 = Clinical experience with FK 506STARZL, T. E; ABU-ELMAGD, K; FUNG, J. J et al.La Presse médicale (1983). 1991, Vol 20, Num 40, pp 1967-1973, issn 0755-4982Article

FK 506: an updateKLINTMALM, G. B.Clinical transplantation. 1994, Vol 8, Num 2, pp 207-210, issn 0902-0063, 2Article

The antimicrobial activities of cyclosporine, FK506, and rapamycinHIGH, K. P.Transplantation. 1994, Vol 57, Num 12, pp 1689-1700, issn 0041-1337Article

The preparation of ¹⁴C-labeled FK-506O'CONNOR, S. P; ELLSWORTH, R. L; OMSTEAD, M. N et al.Journal of labelled compounds & radiopharmaceuticals. 1992, Vol 31, Num 2, pp 103-108, issn 0362-4803Article

Cytomegalovirus retinitis and FK 506CIARDELLA, Antonio P; BARILE, Gaetano; LANGTON, Kevin et al.American journal of ophthalmology. 2003, Vol 136, Num 2, pp 386-389, issn 0002-9394, 4 p.Article

Immunosuppressant switching between cyclosporine and tacrolimus after liver transplantationHASHIKURA, Y; KAWASAKI, S; MAKUUCHI, M et al.Transplantation proceedings. 1996, Vol 28, Num 2, pp 1034-1035, issn 0041-1345Conference Paper

FK 506 rescue therapy for hepatic allograft rejection : experience with an aggressive approachWOODLE, E. S; PERDRIZET, G. A; SO, S. K. S et al.Clinical transplantation. 1995, Vol 9, Num 1, pp 45-52, issn 0902-0063Article

Pediatric intravenous FK506 : how much are we really infusing ?FIRDAOUS, I; HASSOUN, A; OTTE, J.-B et al.Transplantation. 1994, Vol 57, Num 12, pp 1821-1823, issn 0041-1337Article

The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivoCVETKOVIC, M; MANN, G. N; ROMERO, D. F et al.Transplantation. 1994, Vol 57, Num 8, pp 1231-1237, issn 0041-1337Article

Chronopharmacokinetic study of a new immunosuppressive agent, FK 506, in miceFUJIMURA, A; SHIGA, T; OHASHI, K.-I et al.Japanese journal of pharmacology. 1993, Vol 61, Num 2, pp 137-139, issn 0021-5198Article

FK506 and rapamycin modulate the functional activities of human peripheral blood eosinophilsHOM, J. T; ESTRIDGE, T.Clinical immunology and immunopathology (Print). 1993, Vol 68, Num 3, pp 293-300, issn 0090-1229Article

Metabolic effects of cyclosporin A and FK 506 in liver transplant recipientsKRENTZ, A. J; DOUSSET, B; MAYER, D et al.Diabetes (New York, NY). 1993, Vol 42, Num 12, pp 1753-1759, issn 0012-1797Article

FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of PittsburghTHOMSON, A. W; CARROLL, P. B; MCCAULEY, J et al.Springer seminars in immunopathology. 1993, Vol 14, Num 4, pp 323-344, issn 0344-4325Article

Effect of FK 506 and cyclosporine on the expression of IL-6 and its receptor on stimulated monocytesMOUTABARRIK, A; TAKAHARA, S; NAMIKI, M et al.Transplantation proceedings. 1993, Vol 25, Num 3, pp 2320-2321, issn 0041-1345Conference Paper

Effects of a new immunosuppressive agent, FK506, in rats with active Heymann nephritisMATSUKAWA, W; HARA, S; YOSHIDA, F et al.The Journal of laboratory and clinical medicine. 1992, Vol 119, Num 2, pp 116-123, issn 0022-2143Article